A SCOTTISH investment and advisory firm has completed a further seven-figure investment into NeuroClin, a neurological research organisation located at Eurocentral, one of the country’s largest industrial and business hubs located off the M8 in Lanarkshire.
The investment by N4 Partners (N4) further increases the Glasgow-based company’s stake in the business which is described as a “pioneer” in neurological research producing new work into understanding the complex profile of neurological conditions such as Alzheimer’s, Parkinson’s and depression.
Glasgow's N4 sells DBS to US investors
Backed by Foresight Group, Fullbrook Thorpe Investments and N4, NeuroClin has undergone a transformative period which has included the appointment of global pharma executive Jeff Thomis as its chairman and the move into new headquarters at Eurocentral.
It has also launched its maiden Parkinson’s research programme as well as significantly increasing its headcount to about 60 employees, creating new, local jobs in the process.
Allan Dowie, partner at N4, pointed to the firm’s “increased position and partnership in such an exciting business with incredible market opportunities”, adding: “We’re proud to back a business which is producing life-changing research for the millions suffering from neurological conditions worldwide.”
The firm, established in 2020, partners with entrepreneurs and businesses operating across a range of sectors throughout the UK.
NeuroClin was founded in 1999 and has been a leading global centre in Alzheimer’s vaccine research.
Mr Thomis said: “It has been very encouraging to see the meaningful partnerships formed over the last three years enabling the clinic to continue to build on its global reputation and further diversify the research base. A strong platform has been developed and we look ahead to further expansion.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here